Tag Archive for: clinical studies

The Fragile X mutation is a type of genetic mutation called a repeat expansion. This repeat expansion occurs on the FMR1 gene, on the long arm of the X chromosome leading to gene silencing if more than 200 repeats occur.FRAXA Ewsearch Organisation
Partnership

Servier acquires Kaerus Bioscience’s FXS candidate for US$450m

In a US$450m deal with UK-based Kaerus Bioscience Ltd, Servier SA has acquired the development and commercialisation rights to KER-0193, a Phase II-ready drug candidate for the treatment of rare Fragile X syndrome, the most common monogenic cause of autism.

Read more
Richter-Helm´s expanded manufacturing site at Bovenau, Germany on 29.08.2023 Picture: ©Richter-Helm
Biomanufacturing

Manufacturing Biopharmaceuticals

Within the competitive CDMO market, Richter-Helm has developed into a highly valued partner when it comes to the manufacturing of biopharmaceuticals. Richter-Helm is well recognised by pharmaceutical companies, including Big Pharma, as a professional partner offering flexible CDMO solutions from gene to product, all from one source, including consultancy services. This makes Richter-Helm one of the key players in CDMO business.

Read more